Lymphocytic choriomeningitis virus vaccine
Latest Information Update: 01 May 2002
At a glance
- Originator The Scripps Research Institute
- Class Viral vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Lymphocytic choriomeningitis virus infections
Most Recent Events
- 14 Feb 1995 Preclinical development for Lymphocytic choriomeningitis virus infections in USA (Unknown route)